tirzepatide weight loss percentage Lower Zepbound dose may help maintain in obesity December Blog Post: Tirzepatide, Worth

Clinicians usually start GLP-1s at a low dose to avoid nausea and other side effects, then slowly increase the dose every 1 to 4 weeks based on your tolerance and blood sugar response

It is designed for women and men who are pleased with their facial appearance but bothered by the excess skin under the chin

Ultimately, your weight loss journey is a personal one, and your Shapely team will be by your side to help you achieve your best results Typically, we find that patients of our weight loss program in Eastvale, California who are taking GLP-1 agonists such as Ozempic and Wegovy will lose 10% of weight by 6 months and 15% within 1 year

Zepbound (tirzepatide) is FDA-approved for weight management

Patients maintaining high protein intake and exercise typically experience the lower end of this range